{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:52:12Z","timestamp":1786981932804,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Projet de Hospitalier de Recherche Clinique (PHRC) inter-r\u00e9gional","award":["IDRCB 2012-100992-41"],"award-info":[{"award-number":["IDRCB 2012-100992-41"]}]},{"DOI":"10.13039\/501100021790","name":"Fondation pour la Recherche sur Alzheimer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003750","name":"Association France Alzheimer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-025-01513-z","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:13:03Z","timestamp":1737072783000},"page":"4009-4022","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A\u03b242 biomarker linked to insula, striatum, thalamus and claustrum in dementia with Lewy bodies"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6107-4783","authenticated-orcid":false,"given":"Vincent","family":"Gabriel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bousiges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Mondino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Cretin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Philippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Demuynck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Loureiro","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Botzung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00e9na","family":"Chabran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"issue":"1","key":"1513_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058.","journal-title":"Neurology"},{"issue":"5","key":"1513_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1159\/000165917","volume":"26","author":"D Aarsland","year":"2008","unstructured":"Aarsland D, Rongve A, Piepenstock Nore S, et al. Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria. Dement Geriatr Cogn Disord. 2008;26(5):445\u201352. https:\/\/doi.org\/10.1159\/000165917.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"6","key":"1513_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.parkreldis.2010.03.007","volume":"16","author":"JE Galvin","year":"2010","unstructured":"Galvin JE, Duda JE, Kaufer DI, Lippa CF, Taylor A, Zarit SH. Lewy body dementia: the caregiver experience of clinical care. Parkinsonism Relat Disord. 2010;16(6):388\u201392. https:\/\/doi.org\/10.1016\/j.parkreldis.2010.03.007.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"1513_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/archneur.59.1.43","volume":"59","author":"OL Lopez","year":"2002","unstructured":"Lopez OL, Becker JT, Kaufer DI, et al. Research evaluation and prospective diagnosis of dementia with Lewy bodies. Arch Neurol. 2002;59(1):43. https:\/\/doi.org\/10.1001\/archneur.59.1.43.","journal-title":"Arch Neurol"},{"key":"1513_CR5","doi-asserted-by":"publisher","unstructured":"Irwin DJ, Hurtig HI. The contribution of tau, amyloid-beta and alpha-synuclein pathology to dementia in Lewy body disorders. J Alzheimer\u2019s Dis Park. 2018;08(04). https:\/\/doi.org\/10.4172\/2161-0460.1000444","DOI":"10.4172\/2161-0460.1000444"},{"issue":"1","key":"1513_CR6","doi-asserted-by":"publisher","first-page":"e12189","DOI":"10.1002\/dad2.12189","volume":"13","author":"A Chatterjee","year":"2021","unstructured":"Chatterjee A, Hirsch-Reinshagen V, Moussavi SA, Ducharme B, Mackenzie IR, Hsiung GR. Clinico-pathological comparison of patients with autopsy-confirmed Alzheimer\u2019s disease, dementia with Lewy bodies, and mixed pathology. Alzheimers Dement Diagn Assess Dis Monit. 2021;13(1):e12189. https:\/\/doi.org\/10.1002\/dad2.12189.","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"issue":"9108","key":"1513_CR7","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/S0140-6736(05)78999-6","volume":"351","author":"C Ballard","year":"1998","unstructured":"Ballard C, Grace J, McKeith L, Holmes C. Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer\u2019s disease. The Lancet. 1998;351(9108):1032\u20133. https:\/\/doi.org\/10.1016\/S0140-6736(05)78999-6.","journal-title":"The Lancet"},{"key":"1513_CR8","volume-title":"Parkinson\u2019s disease and dementia with Lewy bodies","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci USA: Published online; 1998."},{"issue":"4","key":"1513_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ana.23659","volume":"72","author":"DJ Irwin","year":"2012","unstructured":"Irwin DJ, White MT, Toledo JB, et al. Neuropathologic substrates of Parkinson disease dementia. Ann Neurol. 2012;72(4):587\u201398. https:\/\/doi.org\/10.1002\/ana.23659.","journal-title":"Ann Neurol"},{"issue":"1","key":"1513_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.neurobiolaging.2014.07.005","volume":"36","author":"Z Nedelska","year":"2015","unstructured":"Nedelska Z, Ferman TJ, Boeve BF, et al. Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Neurobiol Aging. 2015;36(1):452\u201361. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.07.005.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"1513_CR11","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/acn3.51183","volume":"7","author":"N Spotorno","year":"2020","unstructured":"Spotorno N, Coughlin DG, Olm CA, et al. Tau pathology associates with in vivo cortical thinning in Lewy body disorders. Ann Clin Transl Neurol. 2020;7(12):2342\u201355. https:\/\/doi.org\/10.1002\/acn3.51183.","journal-title":"Ann Clin Transl Neurol"},{"key":"1513_CR12","doi-asserted-by":"publisher","unstructured":"Kapaki E, Paraskevas GP, Emmanouilidou E, Vekrellis K. The diagnostic value of CSF \u03b1-synuclein in the differential diagnosis of dementia with lewy bodies vs. normal subjects and patients with Alzheimer\u2019s disease. Lewis P, ed. PLoS ONE. 2013;8(11):e81654. https:\/\/doi.org\/10.1371\/journal.pone.0081654","DOI":"10.1371\/journal.pone.0081654"},{"issue":"1","key":"1513_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13195-020-00684-5","volume":"12","author":"O Bousiges","year":"2020","unstructured":"Bousiges O, Philippi N, Lavaux T, et al. Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer\u2019s disease and dementia with Lewy bodies from the prodromal stage. Alzheimers Res Ther. 2020;12(1):120. https:\/\/doi.org\/10.1186\/s13195-020-00684-5.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1513_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3233\/JAD-122176","volume":"35","author":"S Slaets","year":"2013","unstructured":"Slaets S, Le Bastard N, Theuns J, et al. Amyloid pathology influences A\u03b21-42 cerebrospinal fluid levels in dementia with Lewy bodies. J Alzheimers Dis. 2013;35(1):137\u201346. https:\/\/doi.org\/10.3233\/JAD-122176.","journal-title":"J Alzheimers Dis"},{"key":"1513_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neurobiolaging.2018.09.004","volume":"73","author":"E Mak","year":"2019","unstructured":"Mak E, Donaghy PC, McKiernan E, et al. Beta amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies. Neurobiol Aging. 2019;73:74\u201381. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.09.004.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1513_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jagp.2013.03.001","volume":"23","author":"P Donaghy","year":"2015","unstructured":"Donaghy P, Thomas AJ, O\u2019Brien JT. Amyloid PET imaging in Lewy body disorders. Am J Geriatr Psychiatry. 2015;23(1):23\u201337. https:\/\/doi.org\/10.1016\/j.jagp.2013.03.001.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"8","key":"1513_CR17","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2967\/jnumed.111.089730","volume":"52","author":"VL Villemagne","year":"2011","unstructured":"Villemagne VL, Ong K, Mulligan RS, et al. Amyloid imaging with 18 F-Florbetaben in Alzheimer disease and other dementias. J Nucl Med. 2011;52(8):1210\u20137. https:\/\/doi.org\/10.2967\/jnumed.111.089730.","journal-title":"J Nucl Med"},{"issue":"1","key":"1513_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13195-019-0537-5","volume":"11","author":"I Van Steenoven","year":"2019","unstructured":"Van Steenoven I, Van Der Flier WM, Scheltens P, Teunissen CE, Lemstra AW. Amyloid-\u03b2 peptides in cerebrospinal fluid of patients with dementia with Lewy bodies. Alzheimers Res Ther. 2019;11(1):83. https:\/\/doi.org\/10.1186\/s13195-019-0537-5.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"1513_CR19","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3233\/JAD-150731","volume":"51","author":"O Bousiges","year":"2016","unstructured":"Bousiges O, Cretin B, Lavaux T, et al. Diagnostic value of cerebrospinal fluid biomarkers (phospho-Tau181, total-Tau, A\u03b242, and A\u03b240) in prodromal stage of Alzheimer\u2019s disease and dementia with Lewy bodies. J Alzheimers Dis. 2016;51(4):1069\u201383. https:\/\/doi.org\/10.3233\/JAD-150731.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"1513_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jnnp-2017-316385","volume":"89","author":"O Bousiges","year":"2018","unstructured":"Bousiges O, Bombois S, Schraen S, et al. Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer\u2019s disease at the prodromal stage. J Neurol Neurosurg Psychiatry. 2018;89(5):467\u201375. https:\/\/doi.org\/10.1136\/jnnp-2017-316385.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"1513_CR21","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/mds.26668","volume":"31","author":"C Abdelnour","year":"2016","unstructured":"Abdelnour C, Van Steenoven I, Londos E, et al. Alzheimer\u2019s disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia. Mov Disord. 2016;31(8):1203\u20138. https:\/\/doi.org\/10.1002\/mds.26668.","journal-title":"Mov Disord"},{"issue":"5","key":"1513_CR22","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","volume":"129","author":"L Walker","year":"2015","unstructured":"Walker L, McAleese KE, Thomas AJ, et al. Neuropathologically mixed Alzheimer\u2019s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol (Berl). 2015;129(5):729\u201348. https:\/\/doi.org\/10.1007\/s00401-015-1406-3.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"4","key":"1513_CR23","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1017\/S1041610211002171","volume":"24","author":"R Watson","year":"2012","unstructured":"Watson R, O\u2019Brien JT, Barber R, Blamire AM. Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study. Int Psychogeriatr. 2012;24(4):532\u201340. https:\/\/doi.org\/10.1017\/S1041610211002171.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"1513_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/mds.22858","volume":"25","author":"JE Lee","year":"2010","unstructured":"Lee JE, Park B, Song SK, Sohn YH, Park H, Lee PH. A comparison of gray and white matter density in patients with Parkinson\u2019s disease dementia and dementia with Lewy bodies using voxel-based morphometry. Mov Disord. 2010;25(1):28\u201334. https:\/\/doi.org\/10.1002\/mds.22858.","journal-title":"Mov Disord"},{"issue":"10","key":"1513_CR25","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1016\/j.ejrad.2014.06.014","volume":"83","author":"J Zhong","year":"2014","unstructured":"Zhong J, Pan P, Dai Z, Shi H. Voxelwise meta-analysis of gray matter abnormalities in dementia with Lewy bodies. Eur J Radiol. 2014;83(10):1870\u20134. https:\/\/doi.org\/10.1016\/j.ejrad.2014.06.014.","journal-title":"Eur J Radiol"},{"key":"1513_CR26","doi-asserted-by":"publisher","unstructured":"Blanc F, Colloby SJ, Philippi N, et al. Cortical thickness in dementia with Lewy bodies and Alzheimer\u2019s disease: a comparison of prodromal and dementia stages. He Y, ed. PLOS ONE. 2015;10(6):e0127396. https:\/\/doi.org\/10.1371\/journal.pone.0127396","DOI":"10.1371\/journal.pone.0127396"},{"issue":"4","key":"1513_CR27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1017\/S1041610215001805","volume":"28","author":"R Watson","year":"2016","unstructured":"Watson R, Colloby SJ, Blamire AM, O\u2019Brien JT. Subcortical volume changes in dementia with Lewy bodies and Alzheimer\u2019s disease. A comparison with healthy aging. Int Psychogeriatr. 2016;28(4):529\u201336. https:\/\/doi.org\/10.1017\/S1041610215001805.","journal-title":"Int Psychogeriatr."},{"key":"1513_CR28","doi-asserted-by":"publisher","unstructured":"Risacher SL, Saykin AJ. Neuroimaging in aging and neurologic diseases. In: Handbook of Clinical Neurology. Vol 167. Elsevier; 2019:191\u2013227. https:\/\/doi.org\/10.1016\/B978-0-12-804766-8.00012-1","DOI":"10.1016\/B978-0-12-804766-8.00012-1"},{"issue":"3","key":"1513_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/mds.26887","volume":"32","author":"D Erskine","year":"2017","unstructured":"Erskine D, Thomas AJ, Attems J, et al. Specific patterns of neuronal loss in the pulvinar nucleus in dementia with Lewy bodies. Mov Disord. 2017;32(3):414\u201322. https:\/\/doi.org\/10.1002\/mds.26887.","journal-title":"Mov Disord"},{"issue":"3","key":"1513_CR30","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/brain\/awl388","volume":"130","author":"JL Whitwell","year":"2007","unstructured":"Whitwell JL, Weigand SD, Shiung MM, et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer\u2019s disease. Brain. 2007;130(3):708\u201319. https:\/\/doi.org\/10.1093\/brain\/awl388.","journal-title":"Brain"},{"issue":"1","key":"1513_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13195-016-0198-6","volume":"8","author":"F Blanc","year":"2016","unstructured":"Blanc F, Colloby SJ, Cretin B, et al. Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer\u2019s disease. Alzheimers Res Ther. 2016;8(1):31. https:\/\/doi.org\/10.1186\/s13195-016-0198-6.","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"1513_CR32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):270\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.008.","journal-title":"Alzheimers Dement"},{"issue":"8","key":"1513_CR33","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B Dubois","year":"2007","unstructured":"Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS\u2013ADRDA criteria. Lancet Neurol. 2007;6(8):734\u201346. https:\/\/doi.org\/10.1016\/S1474-4422(07)70178-3.","journal-title":"Lancet Neurol"},{"key":"1513_CR34","doi-asserted-by":"publisher","unstructured":"Van Steenoven I, Aarsland D, Weintraub D, et al. Cerebrospinal fluid Alzheimer\u2019s disease biomarkers across the spectrum of Lewy body diseases: results from a large multicenter cohort. Zetterberg H, ed. J Alzheimers Dis. 2016;54(1):287\u2013295. https:\/\/doi.org\/10.3233\/JAD-160322","DOI":"10.3233\/JAD-160322"},{"issue":"1","key":"1513_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13195-017-0276-4","volume":"9","author":"D Chiasserini","year":"2017","unstructured":"Chiasserini D, Biscetti L, Eusebi P, et al. Differential role of CSF fatty acid binding protein 3, \u03b1-synuclein, and Alzheimer\u2019s disease core biomarkers in Lewy body disorders and Alzheimer\u2019s dementia. Alzheimers Res Ther. 2017;9(1):52. https:\/\/doi.org\/10.1186\/s13195-017-0276-4.","journal-title":"Alzheimers Res Ther"},{"key":"1513_CR36","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cca.2019.04.078","volume":"495","author":"L Parnetti","year":"2019","unstructured":"Parnetti L, Paciotti S, Farotti L, Bellomo G, Sepe FN, Eusebi P. Parkinson\u2019s and Lewy body dementia CSF biomarkers. Clin Chim Acta. 2019;495:318\u201325. https:\/\/doi.org\/10.1016\/j.cca.2019.04.078.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"1513_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","volume":"154","author":"JL Guo","year":"2013","unstructured":"Guo JL, Covell DJ, Daniels JP, et al. Distinct \u03b1-synuclein strains differentially promote tau inclusions in neurons. Cell. 2013;154(1):103\u201317. https:\/\/doi.org\/10.1016\/j.cell.2013.05.057.","journal-title":"Cell"},{"issue":"2","key":"1513_CR38","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","volume":"105","author":"F Bassil","year":"2020","unstructured":"Bassil F, Brown HJ, Pattabhiraman S, et al. Amyloid-beta (A\u03b2) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of Lewy body disorders with A\u03b2 pathology. Neuron. 2020;105(2):260-275.e6. https:\/\/doi.org\/10.1016\/j.neuron.2019.10.010.","journal-title":"Neuron"},{"issue":"1","key":"1513_CR39","doi-asserted-by":"publisher","first-page":"9437","DOI":"10.1038\/s41598-017-08667-7","volume":"7","author":"D Roquet","year":"2017","unstructured":"Roquet D, Noblet V, Anthony P, et al. Insular atrophy at the prodromal stage of dementia with Lewy bodies: a VBM DARTEL study. Sci Rep. 2017;7(1):9437. https:\/\/doi.org\/10.1038\/s41598-017-08667-7.","journal-title":"Sci Rep"},{"issue":"1","key":"1513_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jagp.2014.07.005","volume":"23","author":"R Watson","year":"2015","unstructured":"Watson R, Colloby SJ, Blamire AM, O\u2019Brien JT. Assessment of regional gray matter loss in dementia with Lewy bodies: a surface-based MRI analysis. Am J Geriatr Psychiatry. 2015;23(1):38\u201346. https:\/\/doi.org\/10.1016\/j.jagp.2014.07.005.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"1513_CR41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40035-022-00325-x","volume":"11","author":"YY Fathy","year":"2022","unstructured":"Fathy YY, Jonkman LE, Bol JJ, et al. Axonal degeneration in the anterior insular cortex is associated with Alzheimer\u2019s co-pathology in Parkinson\u2019s disease and dementia with Lewy bodies. Transl Neurodegener. 2022;11(1):52. https:\/\/doi.org\/10.1186\/s40035-022-00325-x.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"1513_CR42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/ADR-200288","volume":"5","author":"S Pezzoli","year":"2021","unstructured":"Pezzoli S, De Marco M, Zorzi G, Cagnin A, Venneri A. Functional brain connectivity patterns associated with visual hallucinations in dementia with Lewy bodies. J Alzheimers Dis Rep. 2021;5(1):311\u201320. https:\/\/doi.org\/10.3233\/ADR-200288.","journal-title":"J Alzheimers Dis Rep"},{"issue":"34","key":"1513_CR43","doi-asserted-by":"publisher","first-page":"12569","DOI":"10.1073\/pnas.0800005105","volume":"105","author":"D Sridharan","year":"2008","unstructured":"Sridharan D, Levitin DJ, Menon V. A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks. Proc Natl Acad Sci. 2008;105(34):12569\u201374. https:\/\/doi.org\/10.1073\/pnas.0800005105.","journal-title":"Proc Natl Acad Sci"},{"key":"1513_CR44","doi-asserted-by":"publisher","first-page":"102159","DOI":"10.1016\/j.arr.2023.102159","volume":"93","author":"L Kucikova","year":"2024","unstructured":"Kucikova L, Kalabizadeh H, Motsi KG, et al. A systematic literature review of fMRI and EEG resting-state functional connectivity in dementia with Lewy Bodies: underlying mechanisms, clinical manifestation, and methodological considerations. Ageing Res Rev. 2024;93:102159. https:\/\/doi.org\/10.1016\/j.arr.2023.102159.","journal-title":"Ageing Res Rev"},{"issue":"5","key":"1513_CR45","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00702-011-0641-6","volume":"118","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Song YJC, Harding AJ. Striatal \u03b2-amyloid in dementia with Lewy bodies but not Parkinson\u2019s disease. J Neural Transm. 2011;118(5):713\u20139. https:\/\/doi.org\/10.1007\/s00702-011-0641-6.","journal-title":"J Neural Transm"},{"issue":"10","key":"1513_CR46","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1093\/brain\/aww193","volume":"139","author":"L Sarro","year":"2016","unstructured":"Sarro L, Senjem ML, Lundt ES, et al. Amyloid-\u03b2 deposition and regional grey matter atrophy rates in dementia with Lewy bodies. Brain. 2016;139(10):2740\u201350. https:\/\/doi.org\/10.1093\/brain\/aww193.","journal-title":"Brain"},{"issue":"9","key":"1513_CR47","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1093\/brain\/aws211","volume":"135","author":"SJ Colloby","year":"2012","unstructured":"Colloby SJ, McParland S, O\u2019Brien JT, Attems J. Neuropathological correlates of dopaminergic imaging in Alzheimer\u2019s disease and Lewy body dementias. Brain. 2012;135(9):2798\u2013808. https:\/\/doi.org\/10.1093\/brain\/aws211.","journal-title":"Brain"},{"issue":"3","key":"1513_CR48","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1212\/WNL.0000000000003512","volume":"88","author":"AJ Thomas","year":"2017","unstructured":"Thomas AJ, Attems J, Colloby SJ, et al. Autopsy validation of 123 I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology. 2017;88(3):276\u201383. https:\/\/doi.org\/10.1212\/WNL.0000000000003512.","journal-title":"Neurology"},{"issue":"1","key":"1513_CR49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neulet.2009.05.083","volume":"461","author":"ME Kalaitzakis","year":"2009","unstructured":"Kalaitzakis ME, Pearce RKB, Gentleman SM. Clinical correlates of pathology in the claustrum in Parkinson\u2019s disease and dementia with Lewy bodies. Neurosci Lett. 2009;461(1):12\u20135. https:\/\/doi.org\/10.1016\/j.neulet.2009.05.083.","journal-title":"Neurosci Lett"},{"issue":"3","key":"1513_CR50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neulet.2007.01.029","volume":"415","author":"R Yamamoto","year":"2007","unstructured":"Yamamoto R, Iseki E, Murayama N, et al. Correlation in Lewy pathology between the claustrum and visual areas in brains of dementia with Lewy bodies. Neurosci Lett. 2007;415(3):219\u201324. https:\/\/doi.org\/10.1016\/j.neulet.2007.01.029.","journal-title":"Neurosci Lett"},{"issue":"5\u20138","key":"1513_CR51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13195-014-0077-y","volume":"6","author":"M Swirski","year":"2014","unstructured":"Swirski M, Miners JS, De Silva R, et al. Evaluating the relationship between amyloid-\u03b2 and \u03b1-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson\u2019s disease. Alzheimers Res Ther. 2014;6(5\u20138):77. https:\/\/doi.org\/10.1186\/s13195-014-0077-y.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1513_CR52","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13195-019-0568-y","volume":"11","author":"A Botzung","year":"2019","unstructured":"Botzung A, Philippi N, Noblet V, Loureiro De Sousa P, Blanc F. Pay attention to the basal ganglia: a volumetric study in early dementia with Lewy bodies. Alzheimers Res Ther. 2019;11(1):108. https:\/\/doi.org\/10.1186\/s13195-019-0568-y.","journal-title":"Alzheimers Res Ther."},{"issue":"1","key":"1513_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13195-019-0575-z","volume":"12","author":"E Chabran","year":"2020","unstructured":"Chabran E, Noblet V, Loureiro De Sousa P, et al. Changes in gray matter volume and functional connectivity in dementia with Lewy bodies compared to Alzheimer\u2019s disease and normal aging: implications for fluctuations. Alzheimers Res Ther. 2020;12(1):9. https:\/\/doi.org\/10.1186\/s13195-019-0575-z.","journal-title":"Alzheimers Res Ther"},{"issue":"10","key":"1513_CR54","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","volume":"3","author":"G Fairfoul","year":"2016","unstructured":"Fairfoul G, McGuire LI, Pal S, et al. Alpha-synuclein RT -Qu IC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol. 2016;3(10):812\u20138. https:\/\/doi.org\/10.1002\/acn3.338.","journal-title":"Ann Clin Transl Neurol"},{"key":"1513_CR55","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.parkreldis.2020.09.030","volume":"80","author":"KS Chin","year":"2020","unstructured":"Chin KS, Yassi N, Churilov L, Masters CL, Watson R. Prevalence and clinical associations of tau in Lewy body dementias: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2020;80:184\u201393. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.09.030.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"1513_CR56","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/ana.25392","volume":"85","author":"D Coughlin","year":"2019","unstructured":"Coughlin D, Xie SX, Liang M, et al. Cognitive and pathological influences of tau pathology in Lewy body disorders. Ann Neurol. 2019;85(2):259\u201371. https:\/\/doi.org\/10.1002\/ana.25392.","journal-title":"Ann Neurol"},{"issue":"1","key":"1513_CR57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000534552","volume":"13","author":"Z Tufekcioglu","year":"2023","unstructured":"Tufekcioglu Z, Lange J, Pedersen KF, Tysnes OB, Alves G, Emre M. Cognitive profile in Parkinson\u2019s disease dementia patients with low versus normal cerebrospinal fluid amyloid beta. Dement Geriatr Cogn Disord Extra. 2023;13(1):39\u201347. https:\/\/doi.org\/10.1159\/000534552.","journal-title":"Dement Geriatr Cogn Disord Extra"},{"issue":"10","key":"1513_CR58","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/metabo10100380","volume":"10","author":"S Na","year":"2020","unstructured":"Na S, Jeong H, Park JS, Chung YA, Song IU. The impact of amyloid-beta positivity with 18F-florbetaben PET on neuropsychological aspects in Parkinson\u2019s disease dementia. Metabolites. 2020;10(10):380. https:\/\/doi.org\/10.3390\/metabo10100380.","journal-title":"Metabolites"},{"key":"1513_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.parkreldis.2022.05.022","volume":"100","author":"IM Walker","year":"2022","unstructured":"Walker IM, Cousins KA, Siderowf A, et al. Non-tremor motor dysfunction in Lewy body dementias is associated with AD biomarkers. Parkinsonism Relat Disord. 2022;100:33\u20136. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.05.022.","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"1513_CR60","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/jnnp.2007.116830","volume":"79","author":"MD Gjerstad","year":"2008","unstructured":"Gjerstad MD, Boeve B, Wentzel-Larsen T, Aarsland D, Larsen JP. Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson\u2019s disease over time. J Neurol Neurosurg Psychiatry. 2008;79(4):387\u201391. https:\/\/doi.org\/10.1136\/jnnp.2007.116830.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"1513_CR61","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","volume":"55","author":"P Scheltens","year":"1992","unstructured":"Scheltens P, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in \u201cprobable\u201d Alzheimer\u2019s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967\u201372. https:\/\/doi.org\/10.1136\/jnnp.55.10.967.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01513-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-025-01513-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01513-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T09:03:16Z","timestamp":1750496596000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-025-01513-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1513"],"URL":"https:\/\/doi.org\/10.1007\/s11357-025-01513-z","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the local ethics committee (\u201cComit\u00e9 de Protection des Personnes Strasbourg Est IV\u201d [CPP-EST-IV]). All participants provided informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}